The global epidemiology of invasive Candida infections--is the tide turning?

[1]  B. Kullberg,et al.  Deeply invasive candidiasis. , 2002, Infectious disease clinics of North America.

[2]  A. Kapil,et al.  Infections in acute leukemia: an analysis of 240 febrile episodes , 2000, Medical oncology.

[3]  Didier Pittet,et al.  Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. , 1994, JAMA.

[4]  S. M. Martin,et al.  Secular trends in nosocomial infections: 1970-1979. , 1981, The American journal of medicine.

[5]  D. Denning,et al.  Management of deepCandida infection in surgical and intensive care unit patients , 1994, Intensive Care Medicine.

[6]  R N Jones,et al.  National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. , 1998, Diagnostic microbiology and infectious disease.

[7]  T. Hulsey,et al.  Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. , 2001, Pediatrics.

[8]  R. Gaynes,et al.  Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  F. T. P. Group,et al.  International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and Antifungal Susceptibilities of Isolates Collected in 1997 in the United States, Canada, and South America for the SENTRY Program , 1998, Journal of Clinical Microbiology.

[10]  L. Saiman,et al.  National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  B. Bruun,et al.  Fungemia: An increasing problem in a Danish university hospital 1989 to 1994. , 1995, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  E. Roilides,et al.  Invasive candidosis in pediatric patients. , 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  M. Andreoni,et al.  Two-year surveillance on fluconazole susceptibility of Candida spp isolates in a general and university hospital in Rome. , 2001, Diagnostic microbiology and infectious disease.

[14]  A. Barnes,et al.  Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. , 2002, The Journal of hospital infection.

[15]  J. Mcgowan.  Changing etiology of nosocomial bacteremia and fungemia and other hospital-acquired infections. , 1985, Reviews of infectious diseases.

[16]  R. Gaynes,et al.  Major trends in the microbial etiology of nosocomial infection. , 1991, The American journal of medicine.

[17]  A. Tortorano,et al.  European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region. , 2002, The Journal of hospital infection.

[18]  E. Anaissie,et al.  The epidemiology of hematogenous candidiasis caused by different Candida species. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  L. Hutwagner,et al.  Opportunistic candidiasis: an epidemic of the 1980s. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  J. Sobel,et al.  Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  E. Johnson,et al.  Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990–9) , 2001, Epidemiology and Infection.

[22]  J. Fay,et al.  High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studies. , 1990, Seminars in oncology.

[23]  W. Hope,et al.  Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use. , 2002, The Journal of hospital infection.

[24]  D. Armstrong,et al.  Hematogenous infections due to Candida parapsilosis: changing trends in fungemic patients at a comprehensive cancer center during the last four decades. , 2002, Diagnostic microbiology and infectious disease.

[25]  E. Bow,et al.  Antifungal prophylaxis for severely neutropenic chemotherapy recipients , 2002, Cancer.

[26]  B. Lebeau,et al.  Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  W J Martone,et al.  Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. , 1991, The American journal of medicine.

[28]  P. Ruutu,et al.  Nosocomial bloodstream infections in Finnish hospitals during 1999-2000. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  M. Weinstein,et al.  The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. , 1983, Reviews of infectious diseases.

[30]  J. L. López Sastre,et al.  Neonatal sepsis of nosocomial origin: an epidemiological study from the "Grupo de Hospitales Castrillo" , 2002, Journal of perinatal medicine.

[31]  J. Pemán,et al.  [Epidemiology of candidemia in Spain - Multicenter study] , 2002, Revista iberoamericana de micologia.

[32]  A. Johnson,et al.  Evidence for mating of the "asexual" yeast Candida albicans in a mammalian host. , 2000, Science.

[33]  R. Pinner,et al.  The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  G. O’Kane,et al.  Candidaemia in an Australian teaching hospital: relationship to central line and TPN use. , 1998, The Journal of infection.

[35]  R F Woolson,et al.  Hospital-acquired candidemia. The attributable mortality and excess length of stay. , 1988, Archives of internal medicine.

[36]  J. Ferrer.  Vaginal candidosis: epidemiological and etiological factors , 2000, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[37]  J. Edwards.  Invasive candida infections--evolution of a fungal pathogen. , 1991, The New England journal of medicine.

[38]  B. Plikaytis,et al.  Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  W. Gransden,et al.  Management and outcome of bloodstream infections due to Candida species in England and Wales. , 2003, The Journal of hospital infection.

[40]  E. Nagy,et al.  Aetiology and antifungal susceptibility of yeast bloodstream infections in a Hungarian university hospital between 1996 and 2000. , 2002, Journal of medical microbiology.

[41]  Ronald N. Jones,et al.  National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic. , 1998, Diagnostic microbiology and infectious disease.

[42]  E. Kossoff,et al.  Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. , 1998, The Pediatric infectious disease journal.

[43]  M. Halpern,et al.  The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  C. Beck-Sague,et al.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. , 1993, The Journal of infectious diseases.

[45]  M. Larocco,et al.  Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period , 1994, Antimicrobial Agents and Chemotherapy.

[46]  B. Millar,et al.  Trends in the epidemiology of Candida bloodstream infections in Northern Ireland between January 1984 and December 2000. , 2002, The Journal of infection.

[47]  Edwards Je,et al.  Severe Candidal Infections: Clinical Perspective, Immune Defense Mechanisms, and Current Concepts of Therapy , 1978 .

[48]  A. Voss.  Therapeutic approach to the patient with candidemia , 1999 .

[49]  H. Marais,et al.  Report on the Global HIV/AIDS Epidemic: July 2002 , 2002 .

[50]  A. Brown.  Overview of fungal infections in cancer patients. , 1990, Seminars in oncology.

[51]  H. Paganini,et al.  Risk factors for nosocomial candidaemia: a case-control study in children. , 2002, The Journal of hospital infection.

[52]  J. Enders,et al.  Infectious Diseases Society of America. , 1969, Antimicrobial agents and chemotherapy.

[53]  D. Pittet,et al.  Secular Trends of Candidemia Over 12 Years in Adult Patients at a Tertiary Care Hospital , 2002, Medicine.

[54]  M. Fariñas,et al.  Candidemia in a Tertiary Care Hospital: Epidemiology and Factors Influencing Mortality , 2003, European Journal of Clinical Microbiology and Infectious Diseases.

[55]  J. Verhoef,et al.  International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe). , 1999, Diagnostic microbiology and infectious disease.

[56]  D. Kaufman,et al.  Fluconazole prophylaxis against fungal colonization and infection in preterm infants. , 2001, The New England journal of medicine.

[57]  D. McClish,et al.  Nosocomial bloodstream infections in United States hospitals: a three-year analysis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[58]  J. A. J. W. Kluytmans,et al.  Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[59]  Alexander D. Johnson,et al.  White-Opaque Switching in Candida albicans Is Controlled by Mating-Type Locus Homeodomain Proteins and Allows Efficient Mating , 2002, Cell.

[60]  M. Finland,et al.  Bacteremia at Boston City Hospital: Occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital-acquired cases. , 1975, The Journal of infectious diseases.